BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rethinking Clinical Trials
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230331T130000
DTEND;TZID=America/New_York:20230331T140000
DTSTAMP:20260427T202233
CREATED:20230228T153253Z
LAST-MODIFIED:20230321T120921Z
UID:29375-1680267600-1680271200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 31\, 2023: Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA): Results From A Randomized Controlled Trial (Jody D. Ciolino\, PhD)
DESCRIPTION:Speaker: \nJody D. Ciolino\, PhD\nAssociate Professor\nDirector\, Master of Science in Biostatistics\nDepartment of Preventive Medicine – Biostatistics\nBiostatistics Collaboration Center (BCC) / Northwestern University Data Analysis and Coordinating Center (NUDACC)\nNorthwestern University Feinberg School of Medicine \nTopic: Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA): Results From A Randomized Controlled Trial \nDate: Friday\, March 31\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-31-2023-efficacy-and-safety-of-a-quadruple-ultra-low-dose-treatment-for-hypertension-quartet-usa-results-from-a-randomized-controlled-trial-mark-huffman-md-mph-jody-d-ciol/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230324T130000
DTEND;TZID=America/New_York:20230324T140000
DTSTAMP:20260427T202233
CREATED:20230228T132153Z
LAST-MODIFIED:20230228T132153Z
UID:29371-1679662800-1679666400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 24\, 2023: From Observational Studies to Pragmatic Clinical Trials: (Almost) A Decade of Research in PCORnet® (Erin Holve\, PhD\, MPH\, MPP; Russell Rothman\, MD\, MPP; Schuyler Jones\, MD; Neha Pagidipati\, MD\, MPH)
DESCRIPTION:Speaker: \nErin Holve\, PhD\, MPH\, MPP\nChief Research Infrastructure Officer\,\nPatient-Centered Outcomes Research Institute (PCORI) \nRussell Rothman. MD\, MPP\nDirector Institute for Medicine and Public Health and Senior Vice President\, Population and Public Health\, Vanderbilt University Medical Center \nSchuyler Jones\, MD\,\nAssociate Professor\, Duke Clinical Research Institute and Population Health Sciences\,\nDuke University School of Medicine \nNeha Pagidipati\, MD\, MPH\,\nAssociate Professor\, Duke Clinical Research Institute\nDuke University School of Medicine \nTopic: From Observational Studies to Pragmatic Clinical Trials: (Almost) A Decade of Research in PCORnet®\nDate: Friday\, March 24\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-24-2023-from-observational-studies-to-pragmatic-clinical-trials-almost-a-decade-of-research-in-pcornet-erin-holve-phd-mph-mpp-russell-rothman-md-mpp-schuyler-jone/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230317T130000
DTEND;TZID=America/New_York:20230317T140000
DTSTAMP:20260427T202233
CREATED:20230203T150753Z
LAST-MODIFIED:20230203T150753Z
UID:29125-1679058000-1679061600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 17\, 2023: Patient-Reported Outcomes for Symptom and Adverse Event Monitoring in Oncology (Ethan Basch\, MD\, MSc)
DESCRIPTION:Speaker: \nEthan Basch\, MD\, MSc\nProfessor and Chief of Oncology\nUniversity of North Carolina \nTopic: Patient-Reported Outcomes for Symptom and Adverse Event Monitoring in Oncology\nDate: Friday\, March 17\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-17-2023-patient-reported-outcomes-for-symptom-and-adverse-event-monitoring-in-oncology-ethan-basch-md-msc/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230310T130000
DTEND;TZID=America/New_York:20230310T140000
DTSTAMP:20260427T202233
CREATED:20230203T154329Z
LAST-MODIFIED:20230203T154329Z
UID:29127-1678453200-1678456800@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 10\, 2023: Estimands in Cluster-Randomized Trials: Choosing Analyses that Answer the Right Question (Brennan Kahan\, PhD)
DESCRIPTION:Speaker: \nBrennan Kahan\, PhD\nMRC Clinical Trials Unit\nUniversity College London (UCL) \nTopic: Estimands in Cluster-Randomized Trials: Choosing Analyses that Answer the Right Question\nDate: Friday\, March 10\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-10-2023-estimands-in-cluster-randomized-trials-choosing-analyses-that-answer-the-right-question-brennan-kahan-phd/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230303T130000
DTEND;TZID=America/New_York:20230303T140000
DTSTAMP:20260427T202233
CREATED:20230207T141921Z
LAST-MODIFIED:20230207T141921Z
UID:29150-1677848400-1677852000@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 3\, 2023: Adoption\, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski\, PhD; Stacy Sterling\, DrPH\, MSW)
DESCRIPTION:Speaker: \nMargaret Kuklinski\, PhD\nEndowed Associate Professor of Prevention in Social Work\nDirector\, Social Development Research Group\nActing Director\, Center for Communities That Care\nSchool of Social Work\, University of Washington \nStacy Sterling\, DrPH\, MSW\nKaiser Permanente Division of Research\nCo-Director\, Center for Addiction and Mental Health Research\nAssociate Adjunct Professor\, UCSF Department of Psychiatry and Behavioral Sciences\nAssociate Professor\, Department of Health Systems Science\, Kaiser Permanente Bernard J. Tyson School of Medicine \nTopic: Adoption\, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There?\nDate: Friday\, March 3\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-3-2023-adoption-implementation-and-sustainment-of-family-focused-prevention-in-health-care-systems-how-do-we-get-there-margaret-kuklinski-phd-stacy-sterling-drph-msw/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230224T130000
DTEND;TZID=America/New_York:20230224T140000
DTSTAMP:20260427T202233
CREATED:20230201T144055Z
LAST-MODIFIED:20230216T162942Z
UID:29101-1677243600-1677247200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds February 24\, 2023: S2302 Pragmatica-Lung: New Directions for Decreasing Burden and Increasing Inclusion in NCTN Clinical Trials (Konstantin Dragnev\, MD; Karen Reckamp\, MD\, MS)
DESCRIPTION:Speaker: \nKonstantin Dragnev\, MD\nProfessor of Medicine\, Hematology/Oncology\nIrene Heinz Given Professor in Pharmacology\nAssociate Director for Clinical Research\nPrincipal Investigator – Dartmouth Lead Academic Participating Site for NCTN\nDartmouth Cancer Center\nDartmouth Health \nKaren Reckamp\, MD\, MS\nDirector\, Division of Medical Oncology\nAssociate Director\, Clinical Research\nClinical Professor\, Department of Medicine \nTopic: S2302 Pragmatica-Lung: New Directions for Decreasing Burden and Increasing Inclusion in NCTN Clinical Trials\nDate: Friday\, February 24\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-february-24-2023-s2302-pragmatica-lung-new-directions-for-decreasing-burden-and-increasing-inclusion-in-nctn-clinical-trials-konstantin-dragnev-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230217T130000
DTEND;TZID=America/New_York:20230217T140000
DTSTAMP:20260427T202233
CREATED:20230213T164808Z
LAST-MODIFIED:20230213T164808Z
UID:29210-1676638800-1676642400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds February 17\, 2023: The Heartline Trial: A New Paradigm in Conducting Virtual Clinical Trials (Michael Gibson\, MS\, MD)
DESCRIPTION:Speaker: \nMichael Gibson\, M.S.\, M.D.\nProfessor of Medicine Harvard\nInterventional Cardiologist BI Lahey\nCEO & President of the non-Profit Baim Institute for Clinical Research & PERFUSE Study Group \nTopic: The Heartline Trial: A New Paradigm in Conducting Virtual Clinical Trials\nDate: Friday\, February 17\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-february-17-2023-the-heartline-trial-a-new-paradigm-in-conducting-virtual-clinical-trials-michael-gibson-ms-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230210T130000
DTEND;TZID=America/New_York:20230210T140000
DTSTAMP:20260427T202233
CREATED:20220809T193327Z
LAST-MODIFIED:20230110T155440Z
UID:27761-1676034000-1676037600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds Ethics and Regulatory Series February 10: Informing and Consenting: What Are the Goals? (P. Pearl O'Rourke\, MD; David S. Wendler\, PhD\, MA; Miguel Vazquez\, MD; P. Michael Ho\, MD\, PhD)
DESCRIPTION:Speaker: \nP. Pearl O’Rourke\, MD (retired)\nHarvard Medical School \nDavid S. Wendler\, PhD\, MA\nSenior Researcher\nHead\, Section on Research Ethics\nDepartment of Bioethics\nNIH Clinical Center \nMiguel Vazquez\, MD\nProfessor of Internal Medicine\nUT Southwestern Medical Center \nP. Michael Ho\, MD\, PhD\nProfessor of Medicine\nUniversity of Colorado School of Medicine \nTopic: Informing and Consenting: What Are the Goals?\nDate: Friday\, February 10\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-ethics-and-regulatory-series-february-10-informing-and-consenting-what-are-the-goals-p-pearl-orourke-md-david-s-wendler-phd-ma-miguel-vazquez-md-p-michael-ho-md-phd/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230203T130000
DTEND;TZID=America/New_York:20230203T140000
DTSTAMP:20260427T202233
CREATED:20230110T160333Z
LAST-MODIFIED:20230201T130322Z
UID:28960-1675429200-1675432800@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds February 3\, 2023: Pragmatic Trials For Children With Congenital Heart Disease: Insights From The NITRIC Trial (Luregn Schlapbach\, PhD\, FCICM)
DESCRIPTION:Speaker: \nProf Luregn Schlapbach\, PhD\, FCICM\nHead\, Department of Intensive Care and Neonatology\nUniversity Children`s Hospital\, Zurich\nZurich\, Switzerland\nThe University of Queensland\nBrisbane\, Australia \nTopic: Pragmatic Trials For Children With Congenital Heart Disease: Insights From The NITRIC Trial\nDate: Friday\, February 3\, 2023\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-february-3-2023-pragmatic-trials-for-children-with-congenital-heart-disease-insights-from-the-nitric-trial-luregn-schlapbach-phd-fcicm/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230127T130000
DTEND;TZID=America/New_York:20230127T140000
DTSTAMP:20260427T202233
CREATED:20221221T141408Z
LAST-MODIFIED:20230110T155337Z
UID:28886-1674824400-1674828000@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds January 27\, 2023: The PREPARE II Trial: Embedding a Pragmatic Trial Into Clinical Care During an Emergency Procedure (Derek W. Russell\, MD; Matthew W. Semler\, MD\, MSc)
DESCRIPTION:Speaker: \nDerek W. Russell\, MD\nAssistant Professor\, Department of Medicine\nCo-Director\, Program in Medical ICU Research\nDivision of Pulmonary\, Allergy & Critical Care Medicine\nAssistant Medical Director\, Birmingham Veterans Affairs Medical Center MICU\nUniversity of Alabama at Birmingham Heersink School of Medicine \nMatthew W. Semler\, MD\, MSc\nAssistant Professor of Medicine and Biomedical Informatics\nMedical Director\, Center for Learning Healthcare\, Vanderbilt Institute for Clinical and Translational Research\nVanderbilt University Medical Center \nTopic: The PREPARE II Trial: Embedding a Pragmatic Trial Into Clinical Care During an Emergency Procedure\nDate: Friday\, January 27\, 2023\, 1:00-2:00 p.m. ET \n  \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-january-27-2023-the-prepare-ii-trial-embedding-a-pragmatic-trial-into-clinical-care-during-an-emergency-procedure-derek-w-russell-md-matthew-w-semler-md-msc/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230120T130000
DTEND;TZID=America/New_York:20230120T140000
DTSTAMP:20260427T202233
CREATED:20230106T145038Z
LAST-MODIFIED:20230110T155303Z
UID:28943-1674219600-1674223200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds January 20\, 2023: Collaborative Pragmatic Trials in Action:  EVOLVE-MI (Mikhail Kosiborod\, MD)
DESCRIPTION:Speaker: \nMikhail Kosiborod\, MD\nVice President of Research\nSaint Luke’s Health System\nProfessor of Medicine\nUniversity of Missouri-Kansas City \nTopic: Collaborative Pragmatic Trials in Action: EVOLVE-MI\nDate: Friday\, January 20\, 2023\, 1:00-2:00 pm ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-january-20-2023-collaborative-pragmatic-trials-in-action-evolve-mi-mikhail-kosiborod-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230113T130000
DTEND;TZID=America/New_York:20230113T140000
DTSTAMP:20260427T202233
CREATED:20220809T192836Z
LAST-MODIFIED:20230110T155214Z
UID:27759-1673614800-1673618400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds Ethics and Regulatory Series January 13: Ethical Considerations When Vulnerable Populations are Subjects in Pragmatic Trials (Emily A. Largent\, JD\, PhD\, RN)
DESCRIPTION:Speaker: \nEmily A. Largent\, JD\, PhD\, RN\nEmanuel & Robert Hart Assistant Professor of Medical Ethics and Health Policy\nDepartment of Medical Ethics and Health Policy\nUniversity of Pennsylvania Perelman School of Medicine \nTopic: Ethical Considerations When Vulnerable Populations are Subjects in Pragmatic Trials\nDate: Friday\, January 13\, 2023\, 1:00-2:00 p.m. ET \n  \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV \nAudio Dial in Options \nUS:  1-646-876-9923\nInternational: https://duke.zoom.us/u/abvw6X2hYV \nMeeting ID: 961 5365 9804\nPasscode: 12345
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-ethics-and-regulatory-series-january-13-ethical-considerations-when-vulnerable-populations-are-subjects-in-pragmatic-trials-emily-a-largent-jd-phd-rn/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230106T130000
DTEND;TZID=America/New_York:20230106T140000
DTSTAMP:20260427T202233
CREATED:20230103T153515Z
LAST-MODIFIED:20230106T144909Z
UID:28910-1673010000-1673013600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds January 6\, 2023: Outpatient Treatment of COVID-19 With Metformin\, Ivermectin\, or Fluvoxamine: 10-Month Follow-up and Effects on Developing Long COVID (Carolyn Bramante\, MD\, MPH; Thomas Murray\, PhD)
DESCRIPTION:Speaker: \nCarolyn Bramante\, MD\, MPH\nDivision of General Internal Medicine\nDepartments of Internal Medicine and Pediatrics\nCore faculty in the Program in Health Disparities Research and the Center for Pediatric Obesity Medicine\nUniversity of Minnesota Medical School \nThomas Murray\, PhD\nDivision of Biostatistics\nCoordinating Centers for Biometric Research\nUniversity of Minnesota School of Public Health \nTopic: Outpatient Treatment of COVID-19 With Metformin\, Ivermectin\, or Fluvoxamine: 10-Month Follow-up and Effects on Developing Long COVID\nDate: Friday\, January 6\, 2023\, 1:00-2:00 pm ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/96153659804?pwd=VmNJVDE5VmtFbUFHY0lZeTM1K0Y5QT09 \nMeeting ID: 961 5365 9804\nPasscode: 12345 \nOne tap mobile \n+16468769923\,\,96153659804#\,\,\,\,*12345# US (New York)\n+16469313860\,\,96153659804#\,\,\,\,*12345# US\nFind your local number: https://duke.zoom.us/u/abvw6X2hYV
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-january-6-2023-outpatient-treatment-of-covid-19-with-metformin-ivermectin-or-fluvoxamine-10-month-follow-up-and-effects-on-developing-long-covid/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221216T130000
DTEND;TZID=America/New_York:20221216T140000
DTSTAMP:20260427T202233
CREATED:20221201T141551Z
LAST-MODIFIED:20221201T141551Z
UID:28769-1671195600-1671199200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds December 16\, 2022: The Use of EHR-Agnostic Clinical Decision Support to Prevent Thromboembolism in Hospitalized Medically Ill Patients (Alex C. Spyropoulos\, MD\, FACP\, FCCP\, FRCPC; Jeffrey Solomon\, BFA)
DESCRIPTION:Speaker: \nAlex C. Spyropoulos\, MD\, FACP\, FCCP\, FRCPC\nProfessor of Medicine – The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell\nProfessor – Institute of Health System Science – The Feinstein Institutes for Medical Research\nSystem Director – Anticoagulation and Clinical Thrombosis Services\nNorthwell Health at Lenox Hill Hospital \nJeffrey Solomon\, BFA\nSenior Director\, Usability Lab\nFeinstein Institutes for Medical Research\, Northwell Health\, Manhasset\, NY \nTopic: The Use of EHR-Agnostic Clinical Decision Support to Prevent Thromboembolism in Hospitalized Medically Ill Patients \nDate: Friday\, December 16\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-december-16-2022-the-use-of-ehr-agnostic-clinical-decision-support-to-prevent-thromboembolism-in-hospitalized-medically-ill-patients-alex-c-spyropoulos-md-facp-fccp-frcpc-jeffrey/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221209T130000
DTEND;TZID=America/New_York:20221209T140000
DTSTAMP:20260427T202233
CREATED:20220809T191636Z
LAST-MODIFIED:20221208T154321Z
UID:27757-1670590800-1670594400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds Ethics and Regulatory Series December 9: The Stepped-Wedge Cluster Randomized Trial: Friend or Foe? (Monica Taljaard\, PhD; David Magnus\, PhD)
DESCRIPTION:Speaker: \nMonica Taljaard\, PhD\nSenior Scientist\, Clinical Epidemiology Program\nOttawa Hospital Research Institute\nFull Professor\, Epidemiology and Community Medicine\nUniversity of Ottawa \nDavid Magnus\, PhD\nThomas A. Raffin Professor of Medicine and Biomedical Ethics and Professor of Pediatrics\, Medicine\, and by courtesy of Bioengineering\nDirector\, Stanford Center for Biomedical Ethics\nAssociate Dean for Research \nTopic: The Stepped-Wedge Cluster Randomized Trial: Friend or Foe?\nDate: Friday\, December 9\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-ethics-and-regulatory-series-december-9-the-stepped-wedge-cluster-randomized-trial-friend-or-foe-monica-taljaard-phd-david-magnus-phd/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221202T130000
DTEND;TZID=America/New_York:20221202T140000
DTSTAMP:20260427T202233
CREATED:20221027T145816Z
LAST-MODIFIED:20221130T142912Z
UID:28503-1669986000-1669989600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds December 2\, 2022: A Randomized Controlled Trial of a Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Michael Felker\, MD\, MHS)
DESCRIPTION:Speaker: \nG. Michael Felker\, MD\, MHS\nProfessor of Medicine\nDirector\, Cardiovascular and Metabolism Research\, DCRI \nTopic: A Randomized Controlled Trial of a Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned \nDate: Friday\, December 2\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-december-2-2022-a-randomized-controlled-trial-of-mobile-health-intervention-in-heart-failure-and-diabetes-lessons-learned-g-michael-felker-md-mhs/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221118T130000
DTEND;TZID=America/New_York:20221118T140000
DTSTAMP:20260427T202233
CREATED:20221019T211144Z
LAST-MODIFIED:20221019T211144Z
UID:28449-1668776400-1668780000@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds November 18\, 2022: The FIRST-ABC Pragmatic Trials of Non-Invasive Respiratory Support In Children (Padmanabhan Ramnarayan\, MBBS\, MD\, FRCPCH\, FFICM)
DESCRIPTION:Speaker: \nPadmanabhan Ramnarayan (Ram)\, MBBS\, MD\, FRCPCH\, FFICM\nReader in Pediatric Critical Care\nImperial College London \nTopic: The FIRST-ABC Pragmatic Trials of Non-Invasive Respiratory Support In Children \nDate: Friday\, November 18\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-november-18-2022-the-first-abc-pragmatic-trials-of-non-invasive-respiratory-support-in-children-padmanabhan-ramnarayan-mbbs-md-frcpch-fficm/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221111T130000
DTEND;TZID=America/New_York:20221111T140000
DTSTAMP:20260427T202233
CREATED:20220809T191046Z
LAST-MODIFIED:20220809T191046Z
UID:27755-1668171600-1668175200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds Ethics and Regulatory Series November 11: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain\, PhD\, MPH; Kayte Spector-Bagdady\, JD\, MBioethics)
DESCRIPTION:Speaker: \nStephanie Morain\, PhD\, MPH\nAssistant Professor\nBerman Institute of Bioethics & Johns Hopkins Bloomberg School of Public Health \nKayte Spector-Bagdady\, JD\, MBioethics\nAssociate Director\, Center for Bioethics & Social Sciences in Medicine\nAssistant Professor of Obstetrics & Gynecology\nUniversity of Michigan Medical School \nTopic: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape\nDate: Friday\, November 11\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-ethics-and-regulatory-series-november-11-data-sharing-and-pragmatic-clinical-trials-law-kayte-spector-bagdady-j/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221104T130000
DTEND;TZID=America/New_York:20221104T140000
DTSTAMP:20260427T202233
CREATED:20221014T144713Z
LAST-MODIFIED:20221102T114334Z
UID:28325-1667566800-1667570400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds November 4\, 2022: The CardioNerds Clinical Trials Network: Pairing Equitable Enrollment With Trainee Development (Amit Goyal\, MD\, MAS)
DESCRIPTION:Speaker: \nAmit Goyal\, MD\, MAS\nInterventional/Structural Fellow\, Cleveland Clinic\nCofounder of CardioNerds \nTopic: The CardioNerds Clinical Trials Network: Pairing Equitable Enrollment With Trainee Development \nDate: Friday\, November 4\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-november-4-2022-the-cardionerds-clinical-trials-network-pairing-equitable-enrollment-with-trainee-development-amit-goyal-md-mas/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221103T150000
DTEND;TZID=America/New_York:20221103T150000
DTSTAMP:20260427T202233
CREATED:20221019T200644Z
LAST-MODIFIED:20221019T200857Z
UID:28441-1667487600-1667487600@rethinkingclinicaltrials.org
SUMMARY:Toward Causal Inference in Cluster Randomized Trials: Estimands and Reflection on Current Practice
DESCRIPTION:Methods: Minds the Gap Webinar Series\n“Toward Causal Inference in Cluster Randomized Trials: Estimands and Reflection on Current Practice”\nFan Li\, PhD; Yale School of Public Health\nNational Institutes of Health\, Office of Disease Prevention \n\n\n\nCluster randomized trials (CRTs) involve randomizing groups of individuals to different interventions. While model-based methods are extensively studied for analyzing CRTs\, there has been little reflection around the treatment effect estimands at the outset. In the first part of this presentation\, we describe two relevant estimands that can be addressed through CRTs and point out that they can differ when the treatment effects vary according to cluster sizes. As a cautionary note\, we demonstrate how choices between different analytic approaches can impact the interpretation of results by fundamentally changing the question being asked. In the second part\, we revisit the linear mixed model as the most commonly used method for analyzing CRTs. The linear mixed model makes stringent assumptions\, including normality\, linearity\, and typically a compound symmetric correlation structure\, all of which may be challenging to verify. However\, under certain conditions\, we show that the linear mixed model consistently estimates the average causal effect under arbitrary misspecification of its working model. Under equal randomization\, its model-based variance estimator\, surprisingly\, remains consistent under model misspecification\, justifying the use of confidence intervals output by standard software. These results hold under both simple and stratified randomization\, and serve as an important causal inference justification for linear mixed models. Caveats and extensions of our findings will also be mentioned. \nFor more information\, visit https://prevention.nih.gov/education-training/methods-mind-gap/toward-causal-inference-cluster-randomized-trials-estimands-and-reflection-current-practice.
URL:https://rethinkingclinicaltrials.org/event/toward-causal-inference-in-cluster-randomized-trials-estimands-and-reflection-on-current-practice/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221028T130000
DTEND;TZID=America/New_York:20221028T140000
DTSTAMP:20260427T202233
CREATED:20220928T180911Z
LAST-MODIFIED:20220928T180911Z
UID:28089-1666962000-1666965600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds October 28: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies\, Randomized Trials\, and Long-Term Safety Surveillance (Emily O'Brien\, PhD\, FAHA; Russell Rothman\, MD\, MPP)
DESCRIPTION:Speaker: \nEmily O’Brien\, PhD\, FAHA\nAssociate Professor\nDuke Clinical Research Institute\nDuke University School of Medicine\nDepartment of Population Health Sciences \nRussell Rothman\, MD\, MPP\nSenior Vice President\, Population and Public Health\nDirector\, Vanderbilt Institute for Medicine and Public Health\nVanderbilt University Medical Center \nTopic: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies\, Randomized Trials\, and Long-Term Safety Surveillance \nDate: Friday\, October 28\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-october-28-the-hero-healthcare-worker-exposure-response-outcomes-program-an-online-community-to-support-observational-studies-randomized-trials-and-long-term-safety-surveillance/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221021T130000
DTEND;TZID=America/New_York:20221021T140000
DTSTAMP:20260427T202233
CREATED:20220922T172648Z
LAST-MODIFIED:20220928T185351Z
UID:28044-1666357200-1666360800@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds October 21: Disinformation\, Cyberthreat\, and Choice: Protecting Patients and Clinical Research From the Digital Triple Threat (Eric Perakslis\, PhD; Andrea Downing)
DESCRIPTION:Speaker: \nEric Perakslis\, PhD\nChief Science & Digital Officer\nDuke Clinical Research Institute\nProfessor\, Department of Population Health Sciences\nChief Research Technology Strategist\nDuke University School of Medicine \nAndrea Downing\nePatient and Security Researcher\nCo-Founder – The Light Collective \nTopic: Disinformation\, Cyberthreat\, and Choice: Protecting Patients and Clinical Research From the Digital Triple Threat \nDate: Friday\, October 21\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-october-21-disinformation-cyberthreat-and-choice-protecting-patients-and-clinical-research-from-the-digital-triple-threat-eric-perakslis-phd-andrea-downing/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221014T130000
DTEND;TZID=America/New_York:20221014T140000
DTSTAMP:20260427T202233
CREATED:20220809T190402Z
LAST-MODIFIED:20220809T190402Z
UID:27753-1665752400-1665756000@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds Ethics and Regulatory Series October 14: Responding (or Not) to Signals of Potential Clinical Significance in Pragmatic Clinical Trials (Joseph Ali\, JD; Leslie J. Crofford\, MD; Tanya Matthews\, PhD)
DESCRIPTION:Speaker: \nJoseph Ali\, JD\nAssistant Professor\, Dept. of International Health\nJohns Hopkins Bloomberg School of Public Health\nCore Faculty & Associate Director for Global Programs\nJohns Hopkins Berman Institute of Bioethics \nTanya Matthews\, PhD\nHRPP Director\nKaiser Permanente Washington \nLeslie J. Crofford\, MD\nWilson Family Chair in Medicine\nProfessor of Medicine and Pathology\, Microbiology & Immunology\nChief\, Division of Rheumatology\nVanderbilt University Medical Center \nTopic: Responding (or Not) to Signals of Potential Clinical Significance in Pragmatic Clinical Trials\nDate: Friday\, October 14\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-ethics-and-regulatory-series-october-14-responding-or-not-to-signals-of-potential-clinical-significance-in-pragmatic-clinical-trials-joseph-ali-jd-leslie-j-crofford-md-tanya-matt/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221007T130000
DTEND;TZID=America/New_York:20221007T140000
DTSTAMP:20260427T202233
CREATED:20220922T172155Z
LAST-MODIFIED:20220922T172155Z
UID:28042-1665147600-1665151200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds October 7: Impact Of Handovers Of Anesthesia Care On Morbidity And Mortality (Melanie Meersch-Dini\, MD)
DESCRIPTION:Speaker: \nMelanie Meersch-Dini\, MD\nProfessor\nDepartment of Anesthesiology\, Intensive Care and Pain Medicine\nUniversity Hospital Münster\, Germany \nTopic: Impact Of Handovers Of Anesthesia Care On Morbidity And Mortality \nDate: Friday\, October 7\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-october-7-impact-of-handovers-of-anesthesia-care-on-morbidity-and-mortality-melanie-meersch-dini-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220930T130000
DTEND;TZID=America/New_York:20220930T140000
DTSTAMP:20260427T202233
CREATED:20220830T130116Z
LAST-MODIFIED:20220907T131908Z
UID:27878-1664542800-1664546400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds September 30: CTTI’s Digital Health Trials Hub: Multi-Stakeholder Resources to Conduct Effective Digital Health Trials (Marianne Chase; Jörg Goldhahn\, MD)
DESCRIPTION:Speaker: \nMarianne Chase\nSenior Director Clinical Trial Operations\nNeurological Clinical Research Institute\nMassachusetts General Hospital \nJörg Goldhahn\, MD\nMedical Director\nDirector of Institute for Translational Medicine\nETH Zurich \nTopic: CTTI’s Digital Health Trials Hub: Multi-Stakeholder Resources to Conduct Effective Digital Health Trials\nDate: Friday\, September 30\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-september-30-cttis-digital-health-trials-hub-multi-stakeholder-resources-to-conduct-effective-digital-health-trials/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220923T130000
DTEND;TZID=America/New_York:20220923T140000
DTSTAMP:20260427T202233
CREATED:20220823T180006Z
LAST-MODIFIED:20220823T180006Z
UID:27822-1663938000-1663941600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds September 23: Effect Of An Intensive Nurse Home Visiting Program On Adverse Birth Outcomes In A Medicaid-Eligible Population (Margaret McConnell\, PhD)
DESCRIPTION:Speaker: \nMargaret McConnell\, PhD\nAssociate Professor\nHarvard T.H. Chan School of Public Health \nTopic: Effect Of An Intensive Nurse Home Visiting Program On Adverse Birth Outcomes In A Medicaid-Eligible Population\nDate: Friday\, September 23\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-september-23-effect-of-an-intensive-nurse-home-visiting-program-on-adverse-birth-outcomes-in-a-medicaid-eligible-population-margaret-mcconnell-phd/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220916T130000
DTEND;TZID=America/New_York:20220916T140000
DTSTAMP:20260427T202233
CREATED:20220907T131517Z
LAST-MODIFIED:20220907T131517Z
UID:27896-1663333200-1663336800@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds September 16: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen\, MD\, PhD\, MPH)
DESCRIPTION:Speaker: \nTor Biering-Sørensen\, MD\, PhD\, MPH\nProfessor in Translational Cardiology and Pragmatic Randomized Trials\nHead of Center for Translational Cardiology and Pragmatic Randomized Trials\nDepartment of Biomedical Sciences\nFaculty of Health and Medical Sciences\nUniversity of Copenhagen\nHead of Cardiovascular Non-Invasive Imaging Research Laboratory\nDepartment of Cardiology\nCopenhagen University Hospital – Herlev and Gentofte \nTopic: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program\nDate: Friday\, September 16\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-september-16-using-nationwide-registries-to-conduct-pragmatic-randomized-trials-the-danflu-program-tor-biering-sorensen-md-phd-mph/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220909T130000
DTEND;TZID=America/New_York:20220909T140000
DTSTAMP:20260427T202233
CREATED:20220802T184153Z
LAST-MODIFIED:20220809T185621Z
UID:27732-1662728400-1662732000@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds Ethics and Regulatory Series September 9: Building an Academic Learning Health System: Why Is It So Hard? (Steven Joffe\, MD\, MPH)
DESCRIPTION:Speaker: \nSteven Joffe\, MD\, MPH\nArt and Ilene Penn Professor and Chair\nDepartment of Medical Ethics & Health Policy\nUniversity of Pennsylvania Perelman School of Medicine \nTopic: Keynote: Building an Academic Learning Health System: Why Is It So Hard?\nDate: Friday\, September 9\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-september-9-building-an-academic-learning-health-system-why-is-it-so-hard-steven-joffe-md-mph/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220826T130000
DTEND;TZID=America/New_York:20220826T140000
DTSTAMP:20260427T202233
CREATED:20220722T165252Z
LAST-MODIFIED:20220722T165252Z
UID:27670-1661518800-1661522400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds August 26: The Diuretic Comparison Project:  A Large Pragmatic Clinical Trial (Areef Ishani\, MD\, MS)
DESCRIPTION:Speaker: \nAreef Ishani\, MD MS\nDirector\, Primary Care and Specialty Medicine Service Line\nMinneapolis VA Health Care System\nProfessor of Medicine\nUniversity of Minnesota \nTopic: The Diuretic Comparison Project: A Large Pragmatic Clinical Trial\nDate: Friday\, August 26\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-august-26-the-diuretic-comparison-project-a-large-pragmatic-clinical-trial-areef-ishani-md-ms/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220819T130000
DTEND;TZID=America/New_York:20220819T140000
DTSTAMP:20260427T202233
CREATED:20220725T171354Z
LAST-MODIFIED:20220725T171354Z
UID:27672-1660914000-1660917600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds August 19: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield\, MD\, MPH; Michelle Kelsey\, MD)
DESCRIPTION:Speaker: \nGerald Bloomfield\, MD\, MPH\nAssociate Professor with Tenure\, Medicine\nAssociate Professor\, Global Health\nDuke University \nMichelle Kelsey\, MD\nAssistant Professor of Medicine\nDuke University School of Medicine \n  \nTopic: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change\nDate: Friday\, August 19\, 2022\, 1:00-2:00 p.m. ET \n  \nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 2622 682 0537\nMeeting Password: 12345 \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-august-19-inclusion-and-diversity-in-clinical-trials-actionable-steps-to-drive-lasting-change-gerald-bloomfield-md-mph-michelle-kelsey-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
END:VCALENDAR